NASDAQ:TRAW | Free Cash Flow | Traws Pharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.58M
2025-12-31-$2.76M
2025-03-31-$5.44M
2024-12-31-$4.04M
2024-03-31-$4.42M
2023-12-31-$4.43M$0.00-$4.43M
2023-03-31-$4.54M
2022-12-31-$3.88M
2022-03-31-$4.3M
2021-12-31-$4.27M
2021-03-31-$6.65M
2020-12-31-$5.47M$0.00-$5.47M
2020-03-31-$6.46M
2019-12-31-$5.36M-$1,000.00-$5.36M
2019-03-31-$6.6M
2018-12-31-$5.41M
2018-03-31-$5.51M
2017-12-31-$4.67M
2017-03-31-$6.06M
2016-12-31-$4.36M
2016-03-31-$4.58M
2015-12-31-$5.04M
2015-03-31-$9.85M
2014-12-31-$14.27M$6,000.00-$14.28M
2014-03-31-$16.17M$72,000.00-$16.24M
2013-12-31-$17.13M$94,000.00-$17.22M
2013-03-31-$13.95M$284,000.00-$14.23M
2012-12-31-$27.72M$148,000.00-$27.87M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$18.19M
2024-12-31-$29.79M
2023-12-31-$17.93M$14,000.00-$17.95M
2022-12-31-$16.29M
2021-12-31-$19.49M
2020-12-31-$23.08M$15,000.00-$23.09M
2019-12-31-$20.83M$55,000.00-$20.89M
2018-12-31-$22.7M
2017-12-31-$23.82M
2016-12-31-$15.81M
2015-12-31-$31.24M
2014-12-31-$57.65M$228,000.00-$57.88M
2013-12-31-$61.38M$609,000.00-$61.99M
2012-12-31$1.63M$279,000.00$1.35M
2011-12-31-$14.17M$256,000.00-$14.43M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.